Radiation Oncology/RTOG Trials/8519
|
RTOG 85-19 (PROSTATE)
- Title: Phase II (title not available)
- Objectives: (not available)
- Protocol: (not available)
- Eligibility: Bulky primary lesions, stage B2 and C, with disease confined to the pelvis
- Enrolled: 31 patients
- Conclusion:
- PMID 2146872 -- Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy. (Pilepich MV, Am J Clin Oncol 1990). Conclusion: The observed toxicity appears acceptable and the response rate encouraging.